agilon health, inc.
AGL
$2.94
$0.0451.56%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.70% | 4.94% | |||
| Total Other Revenue | -10.46% | 0.22% | |||
| Total Revenue | 0.68% | 4.93% | |||
| Cost of Revenue | -5.04% | 3.01% | |||
| Gross Profit | 232.59% | 40.38% | |||
| SG&A Expenses | 9.21% | -2.85% | |||
| Depreciation & Amortization | 5.88% | 4.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.47% | 2.79% | |||
| Operating Income | 79.38% | 20.74% | |||
| Income Before Tax | 98.38% | 10.55% | |||
| Income Tax Expenses | -88.84% | 397.80% | |||
| Earnings from Continuing Operations | 98.23% | 8.59% | |||
| Earnings from Discontinued Operations | 2,087.50% | 154.10% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 111.45% | 10.05% | |||
| EBIT | 79.38% | 20.74% | |||
| EBITDA | 85.02% | 21.99% | |||
| EPS Basic | 111.41% | 10.18% | |||
| Normalized Basic EPS | 98.83% | 12.48% | |||
| EPS Diluted | 111.35% | 11.88% | |||
| Normalized Diluted EPS | 98.83% | 12.48% | |||
| Average Basic Shares Outstanding | 0.22% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.22% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||